Global Precision Medicine Market Size, Share, Trend and Forecast 2026 | TechSci Research

1
2016 2026
Global Precision Medicine Market
FORECAST AND OPPORTUNITIES
www.techsciresearch.com
MARKET INTELLIGENCE . CONSULTING
2

• Table of Contents

S. No. Contents Contents Contents
1. Product Overview Product Overview Product Overview
2. Research Methodology Research Methodology Research Methodology
3. Impact of COVID-19 on Global Precision Medicine Market Impact of COVID-19 on Global Precision Medicine Market Impact of COVID-19 on Global Precision Medicine Market
4. Executive Summary Executive Summary Executive Summary
5. Voice of Customer Voice of Customer Voice of Customer
5.1. Brand Awareness Brand Awareness
5.2. Impact of Precision Medicine on Different Therapeutic Areas Impact of Precision Medicine on Different Therapeutic Areas
5.3. Barriers to Precision Medicine Barriers to Precision Medicine
6. Global Precision Medicine Market Outlook, 2016-2026F Global Precision Medicine Market Outlook, 2016-2026F Global Precision Medicine Market Outlook, 2016-2026F
6.1. Market Size Forecast Market Size Forecast
6.1.1. By Value
6.2. Market Share Forecast Market Share Forecast
6.2.1. By Products Services (Precision Medicine Platforms, Precision Medicine Tools, Precision Medicine Services)
6.2.2. By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Whole Genome Sequencing, Companion Diagnostics, Next Generation Sequencing (NGS), Others)
6.2.3. By Application (Oncology, Cardiology, Respiratory, Neurology, Immunology, Others)
6.2.4. By End User (Pharmaceutical and Biotechnology Companies, Healthcare IT, Diagnostic Companies, Clinical Research Organization, Research Institutes)
6.2.5. By Company
6.2.6. By Region
6.3. Product Market Map Product Market Map Product Market Map
Air Coolers
2
3

• Table of Contents

S. No. Contents Contents Contents Contents Contents
7. North America Precision Medicine Market Outlook, 2016-2026F North America Precision Medicine Market Outlook, 2016-2026F North America Precision Medicine Market Outlook, 2016-2026F North America Precision Medicine Market Outlook, 2016-2026F North America Precision Medicine Market Outlook, 2016-2026F
7.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
7.1.1. By Value By Value By Value
7.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
7.2.1. By Products and Services By Products and Services By Products and Services
7.2.2. By Technology By Technology By Technology
7.2.3. By Application By Application By Application
7.2.4. By End User By End User By End User
7.2.5. By Country By Country By Country
7.3. North America Country Analysis North America Country Analysis North America Country Analysis North America Country Analysis
7.3.1. United States Precision Medicine Market Outlook, 2016-2026F United States Precision Medicine Market Outlook, 2016-2026F United States Precision Medicine Market Outlook, 2016-2026F
7.3.1.1. Market Size Forecast Market Size Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share Forecast Market Share Forecast
7.3.1.2.1. By Products and Services
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End User
4

• Table of Contents

S. No. Contents Contents Contents Contents Contents
7.3.2. Canada Precision Medicine Market Outlook, 2016-2026F Canada Precision Medicine Market Outlook, 2016-2026F Canada Precision Medicine Market Outlook, 2016-2026F
7.3.2.1. Market Size Forecast Market Size Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share Forecast Market Share Forecast
7.3.2.2.1. By Products and Services
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. Mexico Precision Medicine Market Outlook, 2016-2026F Mexico Precision Medicine Market Outlook, 2016-2026F Mexico Precision Medicine Market Outlook, 2016-2026F
7.3.3.1. Market Size Forecast Market Size Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share Forecast Market Share Forecast
7.3.3.2.1. By Products and Services
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End User
5

• Table of Contents

S. No. Contents Contents Contents Contents Contents
8. Europe Precision Medicine Market Outlook, 2016-2026F Europe Precision Medicine Market Outlook, 2016-2026F Europe Precision Medicine Market Outlook, 2016-2026F Europe Precision Medicine Market Outlook, 2016-2026F Europe Precision Medicine Market Outlook, 2016-2026F
8.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
8.1.1. By Value By Value By Value
8.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
8.2.1. By Products and Services By Products and Services By Products and Services
8.2.2. By Technology By Technology By Technology
8.2.3. By Application By Application By Application
8.2.4. By End User By End User By End User
8.2.5. By Country By Country By Country
8.3. Europe Country Analysis Europe Country Analysis Europe Country Analysis Europe Country Analysis
8.3.1. Germany Precision Medicine Market Outlook, 2016-2026F Germany Precision Medicine Market Outlook, 2016-2026F Germany Precision Medicine Market Outlook, 2016-2026F
8.3.1.1. Market Size Forecast Market Size Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share Forecast Market Share Forecast
8.3.1.2.1. By Products and Services
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End User
6

• Table of Contents

S. No. Contents Contents Contents Contents Contents
8.3.2. United Kingdom Precision Medicine Market Outlook, 2016-2026F United Kingdom Precision Medicine Market Outlook, 2016-2026F United Kingdom Precision Medicine Market Outlook, 2016-2026F
8.3.2.1. Market Size Forecast Market Size Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share Forecast Market Share Forecast
8.3.2.2.1. By Products and Services
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. France Precision Medicine Market Outlook, 2016-2026F France Precision Medicine Market Outlook, 2016-2026F France Precision Medicine Market Outlook, 2016-2026F
8.3.3.1. Market Size Forecast Market Size Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share Forecast Market Share Forecast
8.3.3.2.1. By Products and Services
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End User
7

• Table of Contents

S. No. Contents Contents Contents Contents Contents
8.3.4. Italy Precision Medicine Market Outlook, 2016-2026F Italy Precision Medicine Market Outlook, 2016-2026F Italy Precision Medicine Market Outlook, 2016-2026F
8.3.4.1. Market Size Forecast Market Size Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share Forecast Market Share Forecast
8.3.4.2.1. By Products and Services
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Spain Precision Medicine Market Outlook, 2016-2026F Spain Precision Medicine Market Outlook, 2016-2026F Spain Precision Medicine Market Outlook, 2016-2026F
8.3.5.1. Market Size Forecast Market Size Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share Forecast Market Share Forecast
8.3.5.2.1. By Products and Services
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End User
8

• Table of Contents

S. No. Contents Contents Contents Contents Contents
9. Asia-Pacific Precision Medicine Market Outlook, 2016-2026F Asia-Pacific Precision Medicine Market Outlook, 2016-2026F Asia-Pacific Precision Medicine Market Outlook, 2016-2026F Asia-Pacific Precision Medicine Market Outlook, 2016-2026F Asia-Pacific Precision Medicine Market Outlook, 2016-2026F
9.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
9.1.1. By Value By Value By Value
9.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
9.2.1. By Products and Services By Products and Services By Products and Services
9.2.2. By Technology By Technology By Technology
9.2.3. By Application By Application By Application
9.2.4. By End User By End User By End User
9.2.5. By Country By Country By Country
9.3. Asia-Pacific Country Analysis Asia-Pacific Country Analysis Asia-Pacific Country Analysis Asia-Pacific Country Analysis
9.3.1. China Precision Medicine Market Outlook, 2016-2026F China Precision Medicine Market Outlook, 2016-2026F China Precision Medicine Market Outlook, 2016-2026F
9.3.1.1. Market Size Forecast Market Size Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share Forecast Market Share Forecast
9.3.1.2.1. By Products and Services
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9

• Table of Contents

S. No. Contents Contents Contents Contents Contents
9.3.2. India Precision Medicine Market Outlook, 2016-2026F India Precision Medicine Market Outlook, 2016-2026F India Precision Medicine Market Outlook, 2016-2026F
9.3.2.1. Market Size Forecast Market Size Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share Forecast Market Share Forecast
9.3.2.2.1. By Products and Services
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Japan Precision Medicine Market Outlook, 2016-2026F Japan Precision Medicine Market Outlook, 2016-2026F Japan Precision Medicine Market Outlook, 2016-2026F
9.3.3.1. Market Size Forecast Market Size Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share Forecast Market Share Forecast
9.3.3.2.1. By Products and Services
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10

• Table of Contents

S. No. Contents Contents Contents Contents Contents
9.3.4. South Korea Precision Medicine Market Outlook, 2016-2026F South Korea Precision Medicine Market Outlook, 2016-2026F South Korea Precision Medicine Market Outlook, 2016-2026F
9.3.4.1. Market Size Forecast Market Size Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share Forecast Market Share Forecast
9.3.4.2.1. By Products and Services
9.3.4.2.2. By Technology
9.3.4.2.3. By Application
9.3.4.2.4. By End User
9.3.5. Australia Precision Medicine Market Outlook, 2016-2026F Australia Precision Medicine Market Outlook, 2016-2026F Australia Precision Medicine Market Outlook, 2016-2026F
9.3.5.1. Market Size Forecast Market Size Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share Forecast Market Share Forecast
9.3.5.2.1. By Products and Services
9.3.5.2.2. By Technology
9.3.5.2.3. By Application
9.3.5.2.4. By End User
11

• Table of Contents

S. No. Contents Contents Contents Contents Contents
9.3.6. Singapore Precision Medicine Market Outlook, 2016-2026F Singapore Precision Medicine Market Outlook, 2016-2026F Singapore Precision Medicine Market Outlook, 2016-2026F
9.3.6.1. Market Size Forecast Market Size Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share Forecast Market Share Forecast
9.3.6.2.1. By Products and Services
9.3.6.2.2. By Technology
9.3.6.2.3. By Application
9.3.6.2.4. By End User
10. South America Precision Medicine Market Outlook, 2016-2026F South America Precision Medicine Market Outlook, 2016-2026F South America Precision Medicine Market Outlook, 2016-2026F South America Precision Medicine Market Outlook, 2016-2026F South America Precision Medicine Market Outlook, 2016-2026F
10.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
10.1.1. By Value By Value By Value
10.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
10.2.1. By Products and Services By Products and Services By Products and Services
10.2.2. By Technology By Technology By Technology
10.2.3. By Application By Application By Application
10.2.4. By End User By End User By End User
10.2.5. By Country By Country By Country
12

• Table of Contents

S. No. Contents Contents Contents Contents Contents
10.3. South America Country Analysis South America Country Analysis South America Country Analysis South America Country Analysis
10.3.1. Brazil Precision Medicine Market Outlook, 2016-2026F Brazil Precision Medicine Market Outlook, 2016-2026F Brazil Precision Medicine Market Outlook, 2016-2026F
10.3.1.1. Market Size Forecast Market Size Forecast
10.3.1.1.1 By Value
10.3.1.2. Market Share Forecast Market Share Forecast
10.3.1.2.1. By Products and Services
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Argentina Precision Medicine Market Outlook, 2016-2026F Argentina Precision Medicine Market Outlook, 2016-2026F Argentina Precision Medicine Market Outlook, 2016-2026F
10.3.2.1. Market Size Forecast Market Size Forecast
10.3.2.1.1 By Value
10.3.2.2. Market Share Forecast Market Share Forecast
10.3.2.2.1. By Products and Services
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.2.2.4. By End User
13

• Table of Contents

S. No. Contents Contents Contents Contents Contents
10.3.3. Colombia Precision Medicine Market Outlook, 2016-2026F Colombia Precision Medicine Market Outlook, 2016-2026F Colombia Precision Medicine Market Outlook, 2016-2026F
10.3.3.1. Market Size Forecast Market Size Forecast
10.3.3.1.1 By Value
10.3.3.2. Market Share Forecast Market Share Forecast
10.3.3.2.1. By Products and Services
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Middle East Africa Precision Medicine Market Outlook, 2016-2026F Middle East Africa Precision Medicine Market Outlook, 2016-2026F Middle East Africa Precision Medicine Market Outlook, 2016-2026F Middle East Africa Precision Medicine Market Outlook, 2016-2026F Middle East Africa Precision Medicine Market Outlook, 2016-2026F
11.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
11.1.1. By Value By Value By Value
11.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
11.2.1. By Products and Services By Products and Services By Products and Services
11.2.2. By Technology By Technology By Technology
11.2.3. By Application By Application By Application
11.2.4. By End User By End User By End User
11.2.5. By Country By Country By Country
14

• Table of Contents

S. No. Contents Contents Contents Contents Contents
11.3. Middle East Africa Country Analysis Middle East Africa Country Analysis Middle East Africa Country Analysis Middle East Africa Country Analysis
11.3.1. South Africa Precision Medicine Market Outlook, 2016-2026F South Africa Precision Medicine Market Outlook, 2016-2026F South Africa Precision Medicine Market Outlook, 2016-2026F
11.3.1.1. Market Size Forecast Market Size Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share Forecast Market Share Forecast
11.3.1.2.1. By Products and Services
11.3.1.2.2. By Technology
11.3.1.2.3. By Application
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Precision Medicine Market Outlook, 2016-2026F Saudi Arabia Precision Medicine Market Outlook, 2016-2026F Saudi Arabia Precision Medicine Market Outlook, 2016-2026F
11.3.2.1. Market Size Forecast Market Size Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share Forecast Market Share Forecast
11.3.2.2.1. By Products and Services
11.3.2.2.2. By Technology
11.3.2.2.3. By Application
11.3.2.2.4. By End User
15

• Table of Contents

S. No. Contents Contents Contents Contents Contents Contents
11.3.3. UAE Precision Medicine Market Outlook, 2016-2026F UAE Precision Medicine Market Outlook, 2016-2026F UAE Precision Medicine Market Outlook, 2016-2026F UAE Precision Medicine Market Outlook, 2016-2026F
11.3.3.1. 11.3.3.1. Market Size Forecast Market Size Forecast
11.3.3.1.1. By Value
11.3.3.2. 11.3.3.2. Market Share Forecast Market Share Forecast
11.3.3.2.1. By Products and Services
11.3.3.2.2. By Technology
11.3.3.2.3. By Application
11.3.3.2.4. By End User
12. Market Dynamics Market Dynamics Market Dynamics Market Dynamics
12.1. Drivers
12.2. Challenges Challenges Challenges Challenges
13. Market Trends Developments Market Trends Developments Market Trends Developments Market Trends Developments Market Trends Developments Market Trends Developments
14. Competitive Landscape Competitive Landscape Competitive Landscape Competitive Landscape Competitive Landscape Competitive Landscape
14.1. Competition Outlook Competition Outlook Competition Outlook Competition Outlook Competition Outlook
14.2. Company Profiles Company Profiles Company Profiles Company Profiles Company Profiles
14.2.1. 14.2.1. IBM Corporation IBM Corporation IBM Corporation
14.2.2. 14.2.2. F. Hoffmann-La Roche AG F. Hoffmann-La Roche AG F. Hoffmann-La Roche AG
14.2.3. 14.2.3. Thermo Fisher Scientific Inc.  Thermo Fisher Scientific Inc.  Thermo Fisher Scientific Inc. 
16

• Table of Contents

S. No. Contents Contents Contents
14.2.4. Koninklijke Philips N.V.
14.2.5. Illumina, Inc
14.2.6. Quest Diagnostics Inc.
14.2.7. QIAGEN N.V.
14.2.8. AstraZeneca PLC
14.2.9. Agilent Technologies, Inc.
14.2.10. Novartis International AG
14.2.11. NanoString Technologies Inc.
14.2.12. NantHealth, Inc.
14.2.13. Orion Health Inc.
14.2.14. Celcuity Inc.
14.2.15. InsightRX, Inc.
15. Strategic Recommendations Strategic Recommendations Strategic Recommendations
16. About us Disclaimers About us Disclaimers About us Disclaimers
17
Product Overview
18

• Scope of Report
• Product of Interest (POI) Precision Medicine

Precision Medicine is an emerging trend in
healthcare industry which refers to providing
disease treatment and prevention taking into
consideration the individuals genetic makeup,
variability in genes, environment and the
lifestyle of the patient. Additionally, other
factors such as patients age, gender,
pre-existing conditions, and pre-existing
conditions are also taken into consideration.
Basically, precision medicine uses data and
genomics to provide treatment to the patient.
Precision medicine refers to providing medical
treatment based on individual characteristics of
each patient, it does not mean that a drug or
medical device would be designed according to the
patient, but it involves the ability to classify
individuals into subpopulations that differ in
their susceptibility to a particular disease or
in their response to a specific treatment.
Precision medicine as the word itself says means
precise and accurate for every patient.
Market Segmentation
APPLICATION
PRODUCTS SERVICES

• Precision Medicine Platform
• Precision Medicine Tools
• Precision Medicine Ser vices

• Oncology
• Immunology
• Cardiology
• Neurology
• Respiratory
• Others

GLOBAL PRECISION MEDICINE MARKET
TECHNOLOGY
END USER

• Big Data Analytics
• Artificial Intelligence
• Bioinformatics
• Whole Genome Sequencing
• Companion Diagnostics
• Next Generation Sequencing (NGS)
• Others

• Pharmaceutical and Biotechnology Companies
• Healthcare IT
• Diagnostic Companies
• Clinical Research Organization
• Research Institutes

19
Product Overview

• Precision medicine is sometimes defined as right
  treatment for the patient at right time by right
  understanding of his or her condition. This in
  turn improves the overall treatment outcome and
  patient experience. This is possible because of
  the four major attributes of precision medicine.
• The four major attributes of precision medicine
  include personalized, predictive, preventive and
  participatory. Personalized refers to the overall
  understanding of the genetic makeup and genetic
  variation in the patient which drives the
  treatment. While predictive involves the
  identification of the patient condition, how he
  or she will respond to the treatment provided,
  and what can be the future outcomes or
  conditions, etc. This in turn helps in the
  formulation of comprehensive health strategy. The
  preventive attribute comprises of a paradigm
  shift from illness to wellness thereby
  facilitating a proactive approach to health and
  medicine. Lastly, the participatory attribute
  comprises of the patients involvement and
  responsibility in making the choices related to
  the illness, treatment and health as a whole.

Source TechSci Research
20
Research Methodology
21

• Research Methodology

Market Profiling
Data Analysis
Data Collection
Data Validation
Developing List of Respondents
Formulating Questionnaire
In-depth secondary research was conducted to
determine top players in the global precision
medicine market, overall market size and
segmental market size.
The data was scrutinized using MS-Excel,
statistical tools and internal proprietary
database to obtain qualitative and quantitative
insights about the global precision medicine
market.
Data obtained as a result of primary and
secondary research was validated through rigorous
triangulation.
TechSci conducted interviews with industry
experts and industry players for data collection
and verification.
In order to conduct industry experts interviews,
TechSci formulated a detailed discussion guide.
List of industry players and industry specialists
was developed.
Primary Research
Desk Research
Company Analysis

• Recent Developments
• Market Changing Aspects/Dynamics
• Government Policies
• Conclusion

• Market Participants
• Key Strengths

• Identifying Key Opinion Leaders
• Questionnaire Design
• In-depth Interviews

22

• Research Methodology

• Baseline Methodology
• Our dedicated team of industry experts has
  monitored and analyzed various aspects of the
  global precision medicine market. The team has
  analyzed the outlook of various segments of this
  market, while considering the major influencing
  factors such as rising prevalence of chronic
  diseases such as cancer and various genetic
  diseases . The study includes market forecasting,
  which would enable our clients to take better
  decisions while planning their strategy to
  achieve sustainability in the global precision
  medicine market.
• Methodology Followed for Calculation of Market
  Size
• Market Size by Value Market size, in terms of
  value, for the year 2020 was calculated based on
  information collected through exhaustive
  secondary research and primary surveys, with
  various key opinion leaders/stakeholders, such as
  precision medicine companies, market influencers
  end-users, industry experts, and other industry
  participants.
• The team interviewed more than 15 20 precision
  medicine companies, 200 end-users, and 15 20
  industry experts and other value chain
  stakeholders in the global precision medicine
  market to obtain the overall market size from
  2016 to 2020, which was validated by the Delphi
  technique. Taking standard deviation into
  consideration, the market size was averaged out,
  to arrive at the market size data during
  2016-2020.

23

• Research Methodology

• Respondents were asked about the current and
  future market growth rates, market shares by
  products services, technology, application, end
  user, by company and by region. Removing the
  outlier responses, the geometric mean of growth
  estimates and provider wise revenue shares
  generated across various segments were
  considered, to arrive at the final revenue
  shares. Revenue shares generated across various
  segments were further triangulated from other
  stakeholders.
• Methodology Followed for Calculation of Market
  Shares
• Market share by products services, technology,
  application, end user, by company and by region
  were calculated based on the responses received
  through primary surveys with industry experts, in
  which the respondents were asked about the market
  shares or revenue generated from various segments
  of precision medicine market. The final shares
  were calculated by taking the geometric mean of
  the responses gathered from key opinion leaders
  after eliminating the outliers.
• Methodology Followed for Forecasting
• TechSci Research performed periodical checks on
  data collected through the surveys with logic
  checks and analyzed the survey results in
  SPSS/Tableau Software.
• Data triangulation techniques were applied to
  fill the gaps and to present a more meaningful
  picture of the market. To forecast global
  precision medicine market, TechSci Research used
  various forecast techniques such as
• Moving Average
• Time Series Analysis
• Regression Analysis
• Econometric and Judgmental Analysis

24

• Research Methodology

TechSci Research used its own forecast tool,
which is based on the growth of various allied
industries in respective regions. TechSci
Research also used the impact analysis during
short, medium and long term period to estimate
the demand and to reach accurate market numbers.
It should be noted that the figures compiled are
only for the organized market including market
share data. The currency used in the report is
the United States Dollar (USD), with the market
size indicated in USD billion.
Partial List of Companies Interviewed Key Secondary Sources
IBM Corporation F. Hoffmann-La Roche AG Thermo Fischer Scientific Inc. Koninklijke Philips N.V. Illumina Inc. Quest Diagnostics Inc. QIAGEN NV AstraZeneca PLC Agilent Technologies Inc. Novartis International AG NanoString Technologies Inc. NantHealth Inc. Orion Health Inc. Celcuity Inc. InsightRX Inc. World Bank TechSci Research Proprietary Database Knowledge Repository Company Annual Reports Industry Magazines Industry Reports News Dailies Credible Paid Databases FDA
25

• Industry Brief

According to TechSci Research report, Global
Precision Medicine Market By Products Services
(Precision Medicine Platforms, Precision Medicine
Tools, Precision Medicine Services), By
Technology (Big Data Analytics, Artificial
Intelligence, Bioinformatics, Whole Genome
Sequencing, Companion Diagnostics, Next
Generation Sequencing (NGS), Others), By
Application (Oncology, Cardiology, Respiratory,
Neurology, Immunology, Others), By End User
(Pharmaceutical and Biotechnology Companies,
Healthcare IT, Diagnostic Companies, Clinical
Research Organization, Research Institutes), By
Region, Competition Forecast Opportunities,
2026, the global precision medicine market was
valued at USD66.85 billion in 2020 and is
expected to reach USD125.67 billion by
registering a CAGR of 10.65 during the forecast
period due to shift towards precision medicine,
increase in genetic diseases and development of
technologies such as next generation sequencing.
The increasing burden of aging population is
expected to spur the growth of the global
precision medicine market through 2026. The aging
population is susceptible to various chronic and
infectious diseases which require the use of
precision medicine for developing disease
diagnostic kits, procedures, and drugs, among
others. Furthermore, growing adoption of gene
therapy in treatment of different target diseases
especially cancer is expected to support the
growth of the global precision medicine market.
Gene therapy basically focuses on modifying a
persons genes in order to treat or cure a
particular disease or ailment. Examining the
functional effects of genes and different
characteristics and then providing treatment to
the patient by altering the genes are all parts
of gene therapy which in turn adds an advantage
to precision medicine to treat different targeted
diseases. Additionally, the growing adoption of
advanced sequencing technologies such as next
generation sequencing in genomics is further
expected to fuel the growth of the global
precision medicine market. Next generation
sequencing is a high throughput screening
technology which can sequence hundreds to
thousands of genes simultaneously at a higher
sensitivity and in a lower turnaround time can
provide accurate data on patients genetic makeup
which in turn can help the researchers and
medical practitioners develop a more personalized
and precise treatment for the disease or ailment
the patient is suffering from. This in turn is
expected to support the growth of the global
precision medicine market. Besides, growing
advanced sequencing technologies such as long
read sequencing technologies will create
lucrative opportunities for the market growth in
the next few years. However, the developing and
under-developed countries in certain regions
across the globe are still unaware about the
precision medicine technology and its
applications and use. This in turn is expected to
slow down the market growth over the next few
years. Also, there are certain ethical issues
such as violation of privacy rules in terms of
use and circulation of patient data and
misinterpretation of genetic and health data
which pose a major threat to the growth of the
global precision medicine market. The global
precision medicine market is segmented based on
products services, technology, application, end
user, and region. The technology segment can
further be fragmented into big data analytics,
artificial intelligence, bioinformatics, whole
genome sequencing, companion diagnostics, next
generation sequencing (NGS) and others. The
companion diagnostics segment is expected to
witness significant growth over the next few
years on account of growing adoption of
personalized diagnostic tests. Companion
diagnostics include diagnostic tests that can be
used as a companion to therapeutic drugs to
determine its applicability to a specific person.
Companion diagnostic tests are designed based on
a companion biomarker which can predict the
likely response of patient to a drug or also
predict severe toxicity. Growing advances and
focus on companion diagnostics are expected to
open new opportunities for the growth of the
global precision medicine market. Major players
operating in the market include IBM Corporation,
F. Hoffmann-La Roche AG, Thermo Fischer
Scientific Inc., Koninklijke Philips N.V.,
Illumina Inc., Quest Diagnostics Inc., QIAGEN NV,
AstraZeneca PLC, Agilent Technologies Inc.,
Novartis International AG, NanoString
Technologies Inc., NantHealth Inc., Orion Health
Inc., Celcuity Inc., InsightRX Inc., among
others. These companies are adopting organic
strategies such as mergers acquisitions,
product launches, among others in order to stay
competitive in the market and are having an edge
over the other players in the industry. Asia
Pacific precision medicine market is expected to
witness highest growth during the forecast period
on account of the growing geriatric population
especially in countries like Japan, China and
India which are susceptible to various diseases.
Additionally, supportive government policies and
schemes are further expected to support the
market growth through 2026. For instance, in
Singapore, the National Precision Medicine
program and the Three Beyond program were
launched for promoting the uptake of new
technologies and digital infrastructure for
supporting personalized healthcare. said Mr.
Karan Chechi, Research Director with TechSci
Research, a research based global management
consulting firm.
26

• Sample Data - Snapshot

Global Precision Medicine Market Size, By Value
(USD Billion), 2016-2026F
CAGR 2016-2020 By Value xx
CAGR 2021E-2026F By Value xx
North America Precision Medicine Market Share, By
Products Services, By Value, 2016-2026F
United States Precision Medicine Market Share, By
Technology, By Value, 2016-2026F
27

• Report Ordering

Report Name Global Precision Medicine
Market FORECAST AND OPPORTUNITIES 2016 2026
License Type Price
Single User License 4900
Multi-User License 5900
Custom Research License 8900
To View Sample OR Purchase Report  
28
About Us and Disclaimer
TechSci Research is a global market research and
consulting company with offices in the US, UK and
India. TechSci Research provides market research
reports in number of areas to organizations. The
company uses innovative business models that
focus on improving productivity, while ensuring
creation of high-quality reports. The proprietary
forecasting models use various analyses of both
industry-specific and macroeconomic variables on
a state-by-state basis to produce a unique
bottom-up model of a country, regional and
global industry prospects. Combined with the
detailed analysis of company activity and
industry trends, the result is a uniquely rich
evaluation of the opportunities available in the
market.
Related Reports
Global Ultrasound Systems Market By Technology
(Diagnostic Ultrasound 2D Ultrasound, 3D 4D
Ultrasound, Doppler Ultrasound v/s Therapeutic
Ultrasound High-Intensity Focused Ultrasound
(HIFU) v/s Extracorporeal Shockwave Lithotripsy
(ESWL)), By Display Type (Colored v/s Black
White), By Mobility (Mobile v/s Fixed), By
Application (Obstetrics/Gynecology, General
Imaging, Cardiology, Urology), By End User
(Hospitals Clinics, Diagnostic Centers,
Others), By Region, Competition Forecast
Opportunities, 2026 Global Diagnostic Imaging
Market By Product Type ( Architecture
(Open/Closed), By Field Strength (High and
Very-High Field MRI Systems), By Systems
(Ultrasound Systems, Nuclear Imaging Systems,
X-Ray Imaging Systems, CT Scanner, MRI System,
Mammography System, Fluoroscopy), By Portability
(Stationary, Portability), By Application
(OB/Gyn, Orthopaedic, Musculosekeletal, Neuro
Spine, General Imaging, Cardio Thoracic, Breast
health, Others), By End Users (Hospitals,
Diagnostic Imaging Centers, Others), By Region,
Forecast Opportunities, 2016-2026F
TechSci Research North America 708 Third
Avenue, Manhattan, New York, United States Tel
1- 646- 360- 1656 Email sales_at_techsciresearch.co
m www.techsciresearch.com
TechSci Research Europe 54, Old brook,
Bretton, Peterborough, United Kingdom Email
sales_at_techsciresearch.com www.techsciresearch.com
TechSci Research Asia-Pacific B 44, Sector
57, Noida, National Capital Region, U.P. -
India Tel [phone] Email
sales_at_techsciresearch.com www.techsciresearch.com
Disclaimer
The contents of this report are based on
information generally available to the public
from sources believed to be reliable. No
representation is made that it is timely,
accurate or complete. TechSci Research has taken
due care and caution in compilation of data as
this has been obtained from various sources
including which it considers reliable and
firsthand. However, TechSci Research does not
guarantee the accuracy, adequacy or completeness
of any information and it is not responsible for
any errors or omissions or for the results
obtained from the use of such information and
especially states that it has no financial
liability whatsoever to the subscribers / users
of this report. The information herein, together
with all estimates and forecasts, can change
without notice. All the figures provided in this
document are indicative of relative market size
and are strictly for clients internal
consumption. Usage of the same for purpose other
than internal will require prior approval of
TechSci Research.